Tag: Grants (Corporate and Foundation)

  • Lab Animals Face Being Euthanized as Trump Cuts Research


    On April 1, the Trump administration’s effort to slash government funding arrived in Morgantown, W.Va., where federal scientists spent their days studying health and safety threats to American workers. That morning, hundreds of employees at the National Institute for Occupational Safety and Health were notified that they were being terminated and would lose access to the building.

    Left behind were more than 900 lab animals. The institute ultimately managed to relocate about two-thirds of them — primarily mice, as well as a handful of rats — sending them to university labs, according to two facility employees who were recently terminated. The remaining 300 animals, however, were euthanized last week.

    Over the last few months, the Trump administration has taken aim at the American research enterprise, firing scores of federal scientists, rescinding active research grants and proposing drastic cuts to the funding that helps labs keep their lights on.

    These moves, which have left many of scientists out of work and disrupted clinical research, have profound ramifications for the lab animals that serve as the basis for much of the nation’s biomedical research.

    “There are going to be a lot of animals that are going to end up being sacrificed — killed,” said Paul Locke, an expert in laboratory animal law and the use of non-animal alternatives in research at the Johns Hopkins Bloomberg School of Public Health.

    The ultimate toll is difficult to predict, experts said, in part because many of the administration’s actions are embroiled in legal battles. Animal research is also shrouded in secrecy; there are no definitive numbers on how many animals live in U.S. laboratories.

    Many scientists were reluctant to speak openly about what might become of their lab animals, fearing backlash from animal rights activists or retaliation from their employers or the Trump administration. Dozens of interview requests to animal research facilities and researchers went unanswered.

    “I think they’re not talking about it because it’s a situation that, for them, is just a parade of horribles,” Dr. Locke said. “If they are going to keep the animals up, it’s going to be massively expensive. If they’re going to sacrifice the animals, it’s going to cause public outrage.”

    Some animal rights activists are cheering the disruption, even if it means euthanizing animals. But many researchers said they were devastated by what they considered to be the worst of both worlds: the deaths of a lot of animals without any gain in scientific knowledge.

    “We don’t take using animals lightly,” said Kyle Mandler, a pulmonary toxicologist who was among the scientists recently terminated from the National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention. At the time, he was in the middle of a study on the hazardous dusts produced in the manufacturing of certain construction materials. About two dozen of his mice were euthanized last week — the study unfinished, the data uncollected.

    “The fact that their lives and sacrifice will just be a complete waste is equal parts depressing and infuriating,” he said.

    The Department of Health and Human Services did not directly answer questions about the fate of the Morgantown animals. But in an emailed statement, an unnamed H.H.S. official said that the changes at NIOSH were part of a “broader realignment,” in which multiple programs were being consolidated into the new Administration for a Healthy America.

    “Staffing and operational adjustments are occurring in phases,” the statement said. “Animal care operations remain active, and H.H.S. is committed to maintaining compliance with all federal animal welfare standards throughout this transition.”

    In recent years, many countries, including the United States, have begun to move away from animal research, which is expensive, ethically fraught and not always a good predictor of what might happen in humans. This month, the U.S. Food and Drug Administration announced that it planned to “phase out” animal testing for certain kinds of drugs and promote the use of alternatives, such as organoids or “organs on chips,” three-dimensional models of human organs made from lab-grown cells.

    Experts agree that these emerging technologies hold enormous promise. But some say that, for now at least, lab animals remain a critical part of biomedical research and that certain kinds of data can’t be gathered any other way.

    “We want to drive ourselves out of this work,” said Naomi Charalambakis, the director of science policy and communications at Americans for Medical Progress, a nonprofit that advocates the continued use of animals in biomedical research. “But we’re not quite there yet.”

    Lab animal research, which often takes years to plan and conduct, requires steady, predictable funding and experienced veterinarians and technicians to provide day-to-day care. Moves by the Trump administration have thrown all of that into question.

    At the National Institute for Occupational Safety and Health’s Morgantown facility, for instance, the abrupt terminations initially included the animal care staff. “But they fought back and said they were not leaving while animals were in the facility,” said a former lab technician, who asked not to be identified to preserve future employment options.

    After the Trump administration began freezing funding to Harvard this month, researchers developing a new tuberculosis vaccine faced the prospect of having to euthanize their rhesus macaques. The study, and the monkeys, were spared only after a private donor stepped in to provide funding.

    Some animals on shuttered projects could be moved to other labs or institutions, but others may have already received experimental treatments or been exposed to pathogens or toxins. Lab animals, many of which are bred to display certain behaviors or health vulnerabilities, are not wild and cannot simply be released. And the sudden surge of surplus lab animals may be more than the nation’s animal sanctuaries can absorb, experts said.

    Ann Linder, an associate director at the animal law and policy program at Harvard Law School, worries that the fate of many lab animals will come down to the “whims and temperaments” of individual researchers and lab employees.

    “Without oversight, some of those decisions will be poor ones, and many will be made out of callous necessity, without regard for the welfare of the animals in question,” she said in an email.

    Many researchers said that they also worried about the National Institutes of Health’s effort to sharply limit funding for “indirect costs” associated with scientific research, including those related to maintaining animal care facilities.

    A federal judge has barred the N.I.H. from putting these funding caps into place, but the agency has appealed. If the policy goes through, it could be devastating for institutions that do research with nonhuman primates, which are long-lived and expensive to care for.

    The Washington National Primate Research Center, based at the University of Washington, has more than 800 nonhuman primates. A cap on indirect funding would cost the center roughly $5 million a year, forcing it to downsize its colony, said Deborah Fuller, the center’s director.

    It “could destroy the entire infrastructure that we have built,” she said.

    If that happened, the center would make every effort to find new homes for its animals, she added. But other research centers would be facing the same challenges, and primate sanctuaries may not be able to absorb the influx.

    As a last resort, primates may need to be euthanized. “It’s a worst-case scenario,” said Sally Thompson-Iritani, an assistant vice provost at the university’s office of research. “Even though none of us likes to think about it or have to talk about it, it could happen.”

    For some animal rights activists, downsizing the federal animal research enterprise is something to celebrate. “For a lot of these animals, being euthanized before being experimented on is probably a best-case scenario,” said Justin Goodman, a senior vice president at the White Coat Waste Project, a nonprofit that advocates the end of federally funded animal research. (The organization would prefer to see lab animals placed in new homes, he noted.)

    Delcianna Winders, who directs the Animal Law and Policy Institute at Vermont Law and Graduate School, said she hoped these cuts would spell the end of the national primate centers. But she said she was concerned that cuts and layoffs at the U.S. Department of Agriculture, which enforces the federal Animal Welfare Act, would weaken the nation’s “already extremely lax oversight” of lab animal welfare.

    Dr. Locke hopes that this crisis might be a “wake up call” for the nation to move further toward alternatives to animal research. But that transition should happen in a thoughtful way, he said.

    “I don’t think it’s OK to cull millions of animals from research,” Dr. Locke said. “I don’t think that’s societally acceptable. I don’t think it’s scientifically acceptable, and I think we need to recognize that that is a likely outcome.”



    Source link

  • Trump Administration Seeks Artists for ‘Garden of Heroes’ Statues

    Trump Administration Seeks Artists for ‘Garden of Heroes’ Statues



    Those selected would receive up to $200,000 to create one of the 250 sculptures, which will be paid for in part with canceled grants from the National Endowment for the Humanities.



    Source link

  • Judge Extends Block on N.I.H. Medical Research Cuts

    Judge Extends Block on N.I.H. Medical Research Cuts


    A federal judge on Friday agreed to extend an order blocking the National Institutes of Health from reducing grant funding to institutions conducting medical and scientific research until she could come to a more lasting decision.

    Judge Angel Kelley of the Federal District Court for the District of Massachusetts had temporarily blocked the Trump administration’s cuts from taking effect earlier this month, with that hold set to expire on Monday. That teed up an urgent hearing on Friday in which states and associations representing those institutions urged her to consider halting the cuts more permanently.

    The stakes of the lawsuit were put in stark relief during one portion of Friday’s hearing that focused on “irreparable harm,” in which the Judge Kelley asked both sides to explain whether the suspension of the funds amounted to an irreversible blow to the universities and hospitals across the country that depend on the funding.

    The N.I.H. has proposed cutting around $4 billion in grants it provides for “indirect costs,” which it has described as tangential expenditures for things like facilities and administrators, and which it said could be better spent on directly funding research. The proposal envisioned reducing funding for those indirect costs to a 15 percent rate to all institutions that receive funds, which a lawyer for the government said was in line with that of private foundations.

    But the coterie of lawyers representing the states and research institutions argued to the judge that the direct and indirect costs are often intertwined.

    One lawyer asked Judge Kelley to consider a scenario of a researcher doing experiments directly funded through an N.I.H. grant, and a worker disposing of hazardous medical waste produced by all the experiments being run at that facility.

    “It is equally important to the research that both of those people are paid to do their work,” the lawyer said. “The research couldn’t happen without that — nevertheless, one is classified as a direct cost, one is an indirect cost.”

    Lawyers for the plaintiffs ticked through an array of adverse effects that could result from the pause in funding.

    They asked the judge to consider the ramifications of potential layoffs of highly skilled staff members, such as veterinary technicians that oversee animal research and hospital nurses. They warned of clinical trials on new drugs being paused. They argued that many institutions would be unable to bring back employees they had lost once experiments and trials were forced to stop.

    Brian Lee, a lawyer representing the government on Friday, said that the broad effects mentioned at the hearing were largely speculative, part of a “nonspecific aura of urgency” that research institutions had drummed up without showing concrete damages.

    With universities in the middle of admissions season, the plaintiff lawyers described a chaotic environment in which both schools and Ph.D. applicants would need to reassess whether the projects they planned to pursue would be feasible. And they expressed fear for smaller universities that were not likely to be able to fill the unanticipated gap left in their budgets.

    Even at larger schools with hefty endowments, the promise of government funding had already influenced big investments, the plaintiff lawyers said.

    They pointed to a $200 million neuroscience lab at the California Institute of Technology, finished in 2020, that the university expected to pay for in part through the funding.

    “There’s going to be a hole in the research budget at Caltech, and actually a big one,” a lawyer said.

    The plaintiff lawyers said that other groups not involved in the lawsuit, such associations of dental and nursing schools, had also become invested in the outcome, fearing disruptions to their own operations.

    “Are you willing to agree that the plaintiffs will suffer harm?” Judge Kelley asked the government’s lawyer after hearing the long list of examples marshaled by the groups suing.

    “Not irreparable,” Mr. Lee replied.

    He said the states and associations suing the government had other means of recovering the lost funding, such as suing under the Tucker Act, which allows groups to sue the government in contract claims. He added that the 15 percent cap was in line with what private foundations such as the Gates Foundation often agree to.

    Earlier, Mr. Lee repeated the government’s claim that capping “indirect funds” for costs like buildings, utilities and support staff at 15 percent, was simply designed to free up more money to be allocated directly to researchers.

    “I want to be clear about one thing at the outset: This is not cutting down on grant funding,” he said. “This is about changing the slices of the pie, which falls squarely in the executive’s discretion.”

    Lawyers suing to stop the cuts said that capping indirect funds at 15 percent across the board was arbitrary, a standard for challenging agency decisions. They argued that institutions of different sizes naturally have different needs when negotiating with the government, and forcing all to adapt to a 15 percent maximum was unreasonable.

    “A lot of this is driven by economies of scale, right?” one of the lawyers said. “The larger the institution you have, the bigger the building you have, the more you can house multiple projects within that one building — that’s going to change your ratio of direct costs or indirect costs,” she said.



    Source link

  • Hundreds of Artists Call on N.E.A. to Roll Back Trump’s Restrictions

    Hundreds of Artists Call on N.E.A. to Roll Back Trump’s Restrictions


    In one of the first signs of collective pushback to the Trump administration’s arts initiatives, several hundred American artists are calling on the National Endowment for the Arts to roll back restrictions on grants to institutions with programming that promotes diversity or “gender ideology.”

    Among the 463 writers, poets, dancers, visual artists and others who signed the letter are the Pulitzer-winning playwrights Jackie Sibblies Drury, Lynn Nottage and Paula Vogel. There is also one name with striking historical resonance: Holly Hughes, a performance artist who in 1990 was one of the so-called N.E.A. Four, denied funding by the agency because of concern from conservative critics at the height of that era’s culture wars.

    “In some ways this just feels like déjà vu all over again,” Ms. Hughes, now a professor of art and design at the University of Michigan, said in a telephone interview. “These funding restrictions are a good barometer for who is the easy punching bag in American culture at the moment.”

    The artists on Tuesday sent a letter to the N.E.A. objecting to new requirements for grant applicants that the organization put in place this month to comply with executive orders signed by President Trump. One of the requirements is that applicants “not operate any programs promoting ‘diversity, equity, and inclusion’ that violate any applicable federal anti-discrimination laws”; the other is that federal funds not be used “to promote gender ideology,” referring to an executive order, prompted by Mr. Trump’s concern about public policy toward transgender people, that declares that American policy is “to recognize two sexes, male and female.”

    The artists’ letter asks the N.E.A. to “reverse” the changes, saying “abandoning our values is wrong, and it won’t protect us. Obedience in advance only feeds authoritarianism.”

    “Trump and his enablers may use doublespeak to claim that support for artists of color amounts to ‘discrimination’ and that funding the work of trans and women artists promotes ‘gender ideology’ (whatever that is),” the letter adds. “But we know better: the arts are for and represent everybody.”

    The letter was sent to 26 N.E.A. officials on Tuesday morning; the agency has not yet commented.

    The letter-writing effort was spearheaded by Annie Dorsen, a writer and theater director — and a recent law school graduate — who was a recipient of a so-called genius grant from the MacArthur Foundation in 2019. “I felt it was important in this moment to signal to the N.E.A. and to anyone else paying attention that artists were aware of what was happening and not staying silent,” Ms. Dorsen said.

    The changes at the N.E.A. are occurring at the same time that Mr. Trump has assumed control of the John F. Kennedy Center for the Performing Arts. He replaced numerous board members, and the new board appointed him as the center’s chairman; several staffers have been ousted, and some artists have resigned from positions there or canceled appearances.

    Some programming has also been canceled, including a touring production of a musical for young audiences, “Finn,” about a gray shark who wishes to be a glittery fish. The show’s creators believe the tour was canceled because the show’s message of self-acceptance was deemed problematic during the Trump era, but Kennedy Center officials say there was not sufficient interest in the tour from presenters around the country to make it financially viable.



    Source link